Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
20.76
-0.42 (-1.96%)
Aug 10, 2026, 9:30 AM EDT - Market open
Odyssey Therapeutics Employees
Odyssey Therapeutics had 100 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
100
Change
n/a
Growth
n/a
Revenue / Employee
$990
Profits / Employee
-$1,600,270
Market Cap
994.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 100 | 0 | - |
| Dec 31, 2025 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Replimune Group | 465 |
| Geron | 258 |
| Omeros | 175 |
| Sana Biotechnology | 142 |
| Olema Pharmaceuticals | 137 |
| Cullinan Therapeutics | 109 |
| Janux Therapeutics | 108 |
ODTX News
- 4 days ago - Evotec enters R&D collaboration with Odyssey Therapeutics - TheFly
- 4 days ago - Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - PRNewsWire
- 6 days ago - Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 days ago - Odyssey Therapeutics Earnings release: Q2 2026 - Filings
- 6 days ago - Odyssey Therapeutics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Odyssey Therapeutics Slides: Corporate presentation - Filings
- 7 weeks ago - Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Odyssey Therapeutics Quarterly report: Q1 2026 - Filings